Fate Therapeutics
FATE
#9288
Rank
NZ$0.28 B
Marketcap
NZ$2.32
Share price
-4.48%
Change (1 day)
35.74%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2026 (TTM): NZ-$1.82

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$1.90. In 2025 the company made an earnings per share (EPS) of NZ-$2.08 an increase over its 2024 EPS that were of NZ-$2.97.

EPS history for Fate Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.82-12.4%
2025NZ-$2.08-29.88%
2024NZ-$2.97
2022NZ-$5.2730.49%
2021NZ-$4.047.21%
2020NZ-$3.7745.45%
2019NZ-$2.5919.17%
2018NZ-$2.1717.65%
2017NZ-$1.85-3.77%
2016NZ-$1.92-12.4%
2015NZ-$2.19-3.97%
2014NZ-$2.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Becton Dickinson
BDX
NZ$6.52-442.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ-$4.76 150.48%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ-$2.37 24.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$12.62-763.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ-$7.57 298.10%๐Ÿ‡บ๐Ÿ‡ธ USA